Evidence map›Paper›PMID 32990821›Full record

ArticleWiener klinische Wochenschrift2020

[Masterplan 2025 of the Austrian Society of Pneumology (ASP)-the expected burden and management of respiratory diseases in Austria].

Michael Studnicka, Bernhard Baumgartner, Josef Bolitschek, Daniel Doberer, Ernst Eber, Josef Eckmayr, Sylvia Hartl, Peter Hesse, Peter Jaksch, Eveline Kink and 15 more

Abstract read
PubMed Publisher
In one paragraph

Article in Wiener klinische Wochenschrift, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Michael StudnickaLandeskrankenhaus Salzburg, Universitätsklinik für Pneumologie/Lungenheilkunde, Müllner Hauptstraße 48, 5020, Salzburg, Österreich. m.studnicka@salk.at.
Bernhard BaumgartnerAbteilung für Pulmologie, Salzkammergut-Klinikum Vöcklabruck, Vöcklabruck, Österreich.
Josef BolitschekAbteilung für Pneumologie, Ordensklinikum Linz GmbH Elisabethinen, Linz, Österreich.
Daniel DobererKlin. Abteilung für Pulmologie, Medizinische Universität Wien, Wien, Österreich.
Ernst EberUniv.-Klinik für Kinder- und Jugendheilkunde, Medizinische Universität Graz, Graz, Österreich.
Josef EckmayrAbteilung für Lungenkrankheiten, Klinikum Wels-Grieskirchen, Wels, Österreich.
Sylvia Hartl2. Interne Lungenabteilung, Otto Wagner-Spital, Wien, Österreich.
Peter HesseOrdination Dr. Judith & Dr. Peter Hesse, Schwechat, Österreich.
Peter JakschKlin. Abteilung für Thoraxchirurgie, Medizinische Universität Wien, Wien, Österreich.
Eveline KinkLungenabteilung, LKH Graz II - Standort Enzenbach, Gratwein-Straßengel, Österreich.
Meinhard Kneusslehem. 2. Medizinische Abteilung mit Pneumologie, Wilhelminenspital Wien, Wien, Österreich.
Bernd LamprechtKlinik für Lungenheilkunde, Kepler Universitätsklinikum, Linz, Österreich.
Horst OlschewskiKlinische Abteilung für Pulmonologie, LKH-Univ. Klinikum Graz, Graz, Österreich.
Andreas PflegerUniv.-Klinik für Kinder- und Jugendheilkunde, Medizinische Universität Graz, Graz, Österreich.
Wolfgang PohlAbteilung für Atmungs- und Lungenerkrankungen, Krankenhaus Hietzing, Wien, Österreich.
Christian PriorOrdination Univ.-Prof. Dr. Christian Prior, Innsbruck, Österreich.
Christoph PuelacherREHAMED-Tirol GmbH, Innsbruck, Österreich.
Andreas RennerAbteilung für Atmungs- und Lungenerkrankungen, Krankenhaus Hietzing, Wien, Österreich.
Wolfgang SteflitschWahlarzt-Ordination für Lungenheilkunde, Ollersbach bei Neulengbach, Österreich.
Ingrid StelzmüllerOrdination Doz. Dr. Ingrid Stelzmüller, Salzburg, Österreich.
Helmut TäublStandort Natters, Pulmologie, LKH Hochzirl-Natters, Natters, Österreich.
Karin VonbankKlin. Abteilung für Pulmologie, Medizinische Universität Wien, Wien, Österreich.
Marlies WagnerUniv.-Klinik für Kinder- und Jugendheilkunde, Medizinische Universität Graz, Graz, Österreich.
Felix WantkeFAZ Floridsdorfer Allergiezentrum GmbH, Wien, Österreich.
Romana WassKlinik für Lungenheilkunde, Kepler Universitätsklinikum, Linz, Österreich.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scientific Members of the Austrian Society of Pneumology describe the expected development in respiratory health and provide guidance towards patient-oriented and cost-efficient respiratory care in Austria.Methods: In November 2017, respiratory care providers (physicians, nurses, physiotherapists) together with patient's advocacy groups and experts in health development, collaborated in workshops on: respiratory health and the environment, bronchial asthma and allergy, COPD, pediatric respiratory disease, respiratory infections, sleep disorders, interventional pneumology, thoracic oncology and orphan diseases.Results: Respiratory disease is extremely prevalent and driven by ill-health behavior, i.e. cigarette smoking, over-eating and physical inactivity. For the majority of respiratory diseases increased prevalence, but decreased hospitalizations are expected.The following measures should be implemented to deal with future challenges:1. Screening and case-finding should be implemented for lung cancer and COPD.2. E-health solutions (telemedicine, personal apps) should be used to facilitate patient management.3. Regional differences in respiratory care should be reduced through E‑health and harmonization of health insurance benefits across Austria.4. Patient education and awareness, to reduce respiratory health illiteracy should be increased, which is essential for sleep disorders but relevant also for other respiratory diseases.5. Respiratory care should be inter-professional, provided via disease-specific boards beyond lung cancer (for ILDs, sleep, allergy)6. Programs for outpatient's pulmonary rehabilitation can have a major impact on respiratory health.7. Increased understanding of molecular pathways will drive personalized medicine, targeted therapy (for asthma, lung cancer) and subsequently health care costs.

Indexed as

Lung Diseases, ObstructivePulmonary MedicineRespiration DisordersAsthmaAustriaChildCost of IllnessHumansPulmonary Disease, Chronic ObstructiveSocieties, MedicalE‑healthPreventionPublic healthRespiratory

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.